glutamic acid has been researched along with esketamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Berardis, D; Di Giannantonio, M; Fornaro, M; Fraticelli, S; Kim, YK; Martinotti, G; Orsolini, L; Perna, G; Pompili, M; Serafini, G; Tomasetti, C; Valchera, A; Vellante, F; Volpe, U | 1 |
| Alvarez, JC; Choucha, W; Colle, R; Corruble, E; David, DJ; Defaix, C; Etting, I; Gardier, AM; Mendez-David, I; Nguyen, TML; Tritschler, L | 1 |
| Curic, S; Haaf, M; Leicht, G; Mulert, C; Rauh, J; Steinmann, S | 1 |
| Chand, T; Colic, L; Danyeli, LV; Gensberger-Reigl, S; Götting, F; Jollant, F; Kretzschmar, M; Kurzweil, L; Li, M; Liebe, T; Macharadze, T; Munk, MHJ; Opel, N; Refisch, A; Sen, ZD; Speck, O; Wagner, G; Walter, M | 1 |
1 review(s) available for glutamic acid and esketamine
| Article | Year |
|---|---|
An Update on Glutamatergic System in Suicidal Depression and on the Role of Esketamine.
Topics: Administration, Intranasal; Antidepressive Agents; Clinical Trials as Topic; Databases, Factual; Depression; Depressive Disorder, Major; Drug Compounding; Glutamic Acid; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Suicide Prevention; Synaptic Transmission; Time Factors; Treatment Outcome; United States; United States Food and Drug Administration | 2020 |
3 other study(ies) available for glutamic acid and esketamine
| Article | Year |
|---|---|
Intranasal (R, S)-ketamine delivery induces sustained antidepressant effects associated with changes in cortical balance of excitatory/inhibitory synaptic activity.
Topics: Animals; Antidepressive Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Ketamine; Mice; Receptors, N-Methyl-D-Aspartate | 2023 |
Opposite Modulation of the NMDA Receptor by Glycine and S-Ketamine and the Effects on Resting State EEG Gamma Activity: New Insights into the Glutamate Hypothesis of Schizophrenia.
Topics: Biomarkers; Electroencephalography; Glutamic Acid; Humans; Ketamine; Male; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2023 |
Association of the delayed changes in glutamate levels and functional connectivity with the immediate network effects of S-ketamine.
Topics: Antidepressive Agents; Glutamic Acid; Humans; Ketamine; Magnetic Resonance Imaging; Male | 2023 |